Vivaldi board2/15/2024 ![]() Costantino holds BS and JD degrees from Fordham University, and is a Certified Public Accountant.Click here to go to our main page on antennas He recently served as a board member of Valtech Inc., which was sold to Edwards Life Sciences Corporation. Costantino has served and continues to serve as a member of the boards of directors of a number of international and domestic companies in health care and other industries. Costantino began his career at the accounting firm Touche Ross & Co., where he became the firm’s managing tax partner in New York. ![]() He also was Senior Executive Vice President & COO and a Director of Conair, a leading personal care company with over $1 billion of revenues, and was President and a Managing Director of Integrated Resources Acquisition, a leveraged buyout firm. Costantino has over 30 years of private equity and venture experience with NGN Capital LLC, Vivaldi’s lead investor, and previously as a Partner of Walden Partners, a merchant / investment banking firm. ![]() He also is Chairman of the Supervisory Board of Vivaldi Biosciences AG. ![]() John Costantino has served on Vivaldi’s board of directors since 2013. We look forward to his continued service on our board of directors, where his deep industry expertise and relationships provide ongoing value to the company,” Mr. “We thank Douglass Given, MD, PhD, for his vision and service as Vivaldi’s Chairman and CEO. Vivaldi’s DeltaFLU influenza vaccine candidates show exciting promise, and Bill has the ability to drive development of the DeltaFLU platform to its full commercial potential,” said Mr. I am very pleased that he has taken on the position of CEO, and I have every confidence in his leadership as he moves the company into new areas of growth and product development. “Bill Wick has made innumerable important contributions to the financial and operational success of Vivaldi Biosciences. Wick earned an AB in Economics from Stanford University, and an MBA from the JL Kellogg Graduate School of Management at Northwestern University. Wick’s international finance and operating experience includes a sixteen-year career with Vision Capital LLC, a trans-Atlantic venture capital firm investing in high-tech start-ups, where he was Managing Director and CFO. Wick has extensive leadership experience in venture-backed medical and high-tech companies, serving as CFO of Lumendi LLC, a medical device company founding CFO of, an internet retailer and founding CFO of QuickPower, Inc., an alternative energy company. In 2013 he was appointed additionally to the position of Chief Operating Officer and also was named a Managing Director of the company’s European affiliate, Vivaldi Biosciences AG (Vienna, Austria). William (Bill) Wick joined Vivaldi in 2007 as its first Chief Financial Officer. Costantino, Managing General Partner of NGN Capital LLC, was appointed Chairman of the Board of Directors. to the position of Chief Executive Officer. Vivaldi Biosciences Board Appoints William Wick as Chief Executive Officer and John Costantino as Chairmanįort Collins, CO – Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenuated live influenza vaccines for seasonal and pandemic influenza, today announced the appointment of William O.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |